Masayuki Arakawa

3.5k total citations · 1 hit paper
78 papers, 2.8k citations indexed

About

Masayuki Arakawa is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masayuki Arakawa has authored 78 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Surgery and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masayuki Arakawa's work include Muscle Physiology and Disorders (8 papers), Anesthesia and Pain Management (7 papers) and Diabetes Treatment and Management (7 papers). Masayuki Arakawa is often cited by papers focused on Muscle Physiology and Disorders (8 papers), Anesthesia and Pain Management (7 papers) and Diabetes Treatment and Management (7 papers). Masayuki Arakawa collaborates with scholars based in Japan, United States and France. Masayuki Arakawa's co-authors include Yoshio Fujitani, Ryuzo Kawamori, Hirotaka Watada, Takahisa Hirose, Chie Ebato, Kosuke Azuma, Tamotsu Kondo, Ikuzo Tanaka, Seiji Tobita and Tomoya Mita and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cell Metabolism.

In The Last Decade

Masayuki Arakawa

76 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy Is Important in Islet Homeostasis and Compensatory Increase of Beta Cell Mass in Response to High-Fat Diet

2008 637 citations Chie Ebato, Toyoyoshi Uchida et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Masayuki Arakawa

Since Specialization

Citations

This map shows the geographic impact of Masayuki Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Arakawa more than expected).

Fields of papers citing papers by Masayuki Arakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Arakawa. The network helps show where Masayuki Arakawa may publish in the future.

Co-authorship network of co-authors of Masayuki Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Arakawa. A scholar is included among the top collaborators of Masayuki Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Arakawa. Masayuki Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry 2014 ·Biochemical and Biophysical Research Communications ·Masayuki Arakawa, (unknown), Shinichi Tatsumi, (unknown), Kayoko Saito, Akio Nomoto	7
2	IRS-2 deficiency in macrophages promotes their accumulation in the vascular wall 2011 ·Biochemical and Biophysical Research Communications ·Tomoya Mita, Kosuke Azuma, Hiromasa Goto, Wen Jin, Masayuki Arakawa, Takashi Nomiyama, Ryo Suzuki, Naoto Kubota, Kazuyuki Tobe, Takashi Kadowaki, Yoshio Fujitani, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada	8
3	Transcutaneous immunization by a solid-in-oil nanodispersion 2010 ·Chemical Communications ·Yoshiro Tahara, (unknown), Noriho Kamiya, (unknown), (unknown), Masayuki Arakawa, Masahiro Goto	33
4	In vivo Evaluation Method of the Effect of Nattokinase on Carrageenan-Induced Tail Thrombosis in a Rat Model 2010 ·Acta Haematologica ·(unknown), Masayori Hagimori, (unknown), Masayuki Arakawa	39
5	Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model 2009 ·Pharmacological Research ·Masayori Hagimori, (unknown), Yasuchika Yamaguchi, Masayuki Arakawa	44
6	Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying 2009 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Atsuo Miyagishima, Shigeru Itai, Masayuki Arakawa	24
7	Autophagy Is Important in Islet Homeostasis and Compensatory Increase of Beta Cell Mass in Response to High-Fat Diet breakdown → 2008 ·Cell Metabolism ·Chie Ebato, Toyoyoshi Uchida, Masayuki Arakawa, Masaaki Komatsu, Takashi Ueno, Koji Komiya, Kosuke Azuma, Takahisa Hirose, Keiji Tanaka, Eiki Kominami, Ryuzo Kawamori, Yoshio Fujitani, Hirotaka Watada	637
8	A New Terrein Glucoside, a Novel Inhibitor of Angiogenin Secretion in Tumor Angiogenesis 2008 ·The Journal of Antibiotics ·Masayuki Arakawa, Tetsuya Someno, Manabu Kawada, Daishiro Ikeda	46
9	Transforming growth factor-β1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I 2007 ·Molecular Cancer Therapeutics ·Manabu Kawada, Masayuki Arakawa, Hiroyuki Inoue, Isao Momose, Daishiro Ikeda	3
10	Monitoring Compliance in Patients with Hyperlipidemia Using New Electronic Compliance Recorder 2005 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Daiki Tsuji, (unknown), Masayuki Arakawa, Chieko Suzuki, Yoichi Matsumoto, Shinichiro Nishio, Kyoichi Ohashi, Mitsuyoshi Nakashima	1
11	Block of the sacral segments in lumbar epidural anaesthesia 2003 ·British Journal of Anaesthesia ·Masayuki Arakawa, (unknown), Yoko Ohe	13
12	Efficacy of 1% ropivacaine at sacral segments in lumbar epidural anesthesia 2003 ·Regional Anesthesia & Pain Medicine ·Masayuki Arakawa	6
13	Negamycin Restores Dystrophin Expression in Skeletal and Cardiac Muscles of mdx Mice 2003 ·The Journal of Biochemistry ·Masayuki Arakawa	93
14	Consideration of the optimal epidural fentanyl doses in abdominal surgery 1998 ·Journal of Clinical Anesthesia ·Masayuki Arakawa, Sumio Hoka	1
15	Effects of Surfactants and Protease Inhibitors on Nasal Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor(rhG-CSF) in Rats. 1994 ·Biological and Pharmaceutical Bulletin ·Minoru Machida, (unknown), Masayuki Arakawa, Masahiro Hayashi, Shoji Awazu	14
16	Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) from Rat Nasal Mucosa 1993 ·Pharmaceutical Research ·Minoru Machida, (unknown), Masayuki Arakawa, Masahiro Hayashi, Shoji Awazu	17
17	Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents. 1991 ·The Journal of Antibiotics ·Kiyohiro Nishikawa, (unknown), Masaharu Hiratsuka, Masayuki Arakawa, Katsutoshi Takahashi, TOMIO TAKEUCHI	11
18	Hemodynamic effects of nifedipine slow release tablets in patients with essential hypertension 1989 ·Current Therapeutic Research ·(unknown), Tsutomu Hirano, S. Watanabe, Masayuki Arakawa	1
19	Permeability of ethylcellulose microcapsules towards phenobarbital 1984 ·Journal of Microencapsulation ·(unknown), Masayuki Arakawa, Tamotsu Kondo, M. Donbrow	7
20	Size effect on the permeability of ethylcellulose microcapsules towards ions. 1978 ·MEMBRANE ·Y. Ohta, Masayuki Arakawa, Tamotsu Kondo	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact